The global albumin (as excipient) market size is anticipated to reach US$ 1230 Mn by 2026 at a CAGR of over 5.2% from 2019 to 2026. Grant of regulatory approvals coupled with subsequent launch of albumin based products is the key factor expected to propel the market during the forecast period.
Albumin is a water soluble globular protein produced in the liver. It accounts for 50% of blood plasma proteins. These play a vital role in regulating blood volume and act as transporters for molecules such as few hormones, bile salts, and ions. Albumin is commonly used as blood volumizer in rare diseases, burns, shocks, liver conditions, and other blood loss trauma and surgeries.
The report analyzes and forecasts the albumin (as excipient) market at global and regional levels. The market has been forecast based on volume (Tons) and value (US$ Mn) from 2019 to 2026. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level. For the region and all segments, the sales, revenue and their market share, growth rate are key research objects; we can research the manufacturers' sales, price, revenue, cost and gross profit and their changes. What's more, we will display the main consumers, raw material manufacturers, distributors, etc.
This report first introduces the background of albumin (as excipient), including the definition, classification, application, industrial chain structure, industry overview, national policy and planning analysis of the industry, and the latest dynamic analysis. With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major albumin (as excipient) companies.
Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of albumin (as excipient) upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of albumin (as excipient) and consumption, major regions and consumption, major global producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.
The report comprises a detailed value chain analysis, which provides a comprehensive view of the global albumin (as excipient) market. The Porter’s Five Forces model has also been included to help understand the competitive landscape of the market. The study encompasses market attractiveness analysis, wherein various applications have been benchmarked based on their market size, growth rate, and general attractiveness.
The study provides a decisive view of the albumin (as excipient) market by segmenting it in terms of form and application. The segment has been analyzed based on the present and future trends. Regional segmentation includes the current and projected demand in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
The report provides size (in terms of volume and value) of albumin (as excipient) market for the base year 2018 and the forecast between 2019 and 2026. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
Companies Profiled in the Report
The report also profiles major players operating in the global albumin (as excipient) market based on various attributes, such as, company overview, financial overview, product portfolio, business strategies, and recent developments. Major players in the market are Albumedix A/S (Novozyme A/S), Albumin Therapeutics, LLC, Biotest AG, CSL Behring LLC, Grifols International, S.A, HiMedia Laboratories Pvt. Ltd., InVitria, Medxbio Pte Ltd, Octapharma AG, RayBiotech, Inc., SeraCare Life Sciences, and Sigma-Aldrich Co. (Merck KGaA).
The global albumin (as excipient) market has been segmented as given below:
Global Pediatric Health Care Products and Services Market, by Geography
Research Methodology:
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
Primary research represents a bulk of research efforts, supplemented by extensive secondary research. Annual reports, press releases, and relevant documents of key players operating in various application areas have been reviewed for competition analysis and market understanding.
Secondary research also includes recent trends, technical writing, Internet sources, and statistical data from government websites, trade associations, and agencies. These have proved to be reliable, effective, and successful approaches for obtaining precise market data, capturing market participants’ insights, and recognizing business opportunities.
The study objectives of this report are:
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Albumin (as Excipient) Market
4. Market Overview
4.1. Introduction
4.1.1. Product Type Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Albumin (as Excipient) Market Analysis and Forecast, 2019–2026
4.4.1. Market Revenue Projections (US$ Mn)
4.4.2. Market Volume Shipments Projections
4.5. Porter’s Five Force Analysis
5. Market Outlook
5.1. Key Trends
5.2. Competition Landscape Analysis (Based on Recent Developments of Key Players)
5.3. Pricing Assessment, by Product Type
6. Global Albumin (as Excipient) Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value and Volume Forecast, by Product Type, 2019–2026
6.3.1. Human Serum Albumin
6.3.2. Recombinant Albumin
6.4. Market Attractiveness, by Product Type
7. Global Albumin (as Excipient) Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value and Volume Forecast, by Application, 2019–2026
7.3.1. Human Serum Albumin Applications
7.3.1.1. Drug Formulation
7.3.1.2. Drug Delivery
7.3.1.3. Vaccines
7.3.1.4. Medical Device Coating
7.3.1.5. Culture Media & Stabilizers
7.3.1.6. Diagnostics
7.3.1.7. In Vitro Fertilization
7.3.2. Recombinant Albumin Applications
7.3.2.1. Drug Formulation
7.3.2.2. Drug Delivery
7.3.2.3. Vaccines
7.3.2.4. Medical Device Coating
7.3.2.5. Culture Media & Stabilizers
7.3.2.6. Diagnostics
7.3.2.7. In Vitro Fertilization
7.4. Market Attractiveness, by Application
8. Global Albumin (as Excipient) Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by End-user, 2019–2026
8.3.1. Pharmaceutical & Biotechnology Industry
8.3.2. Research Institutes
8.3.3. Others
8.4. Market Attractiveness, by End-user
9. Global Albumin (as Excipient) Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value and Volume Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Rest of the World
9.3. Market Attractiveness, by Country/Region
10. North America Albumin (as Excipient) Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value and Volume Forecast, by Product Type, 2019–2026
10.2.1. Human Serum Albumin
10.2.2. Recombinant Albumin
10.3. Market Value and Volume Forecast, by Application, 2019–2026
10.3.1. Human Serum Albumin Applications
10.3.1.1. Drug Formulation
10.3.1.2. Drug Delivery
10.3.1.3. Vaccines
10.3.1.4. Medical Device Coating
10.3.1.5. Culture Media & Stabilizers
10.3.1.6. Diagnostics
10.3.1.7. In Vitro Fertilization
10.3.2. Recombinant Albumin Applications
10.3.2.1. Drug Formulation
10.3.2.2. Drug Delivery
10.3.2.3. Vaccines
10.3.2.4. Medical Device Coating
10.3.2.5. Culture Media & Stabilizers
10.3.2.6. Diagnostics
10.3.2.7. In Vitro Fertilization
10.4. Market Value Forecast, by End-user, 2019–2026
10.4.1. Pharmaceutical & Biotechnology Industry
10.4.2. Research Institutes
10.4.3. Others
10.5. Market Value and Volume Forecast, by Country, 2019–2026
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. by Product Type
10.6.2. by Application
10.6.3. by End-user
10.6.4. by Country
11. Europe Albumin (as Excipient) Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value and Volume Forecast, by Product Type, 2019–2026
11.2.1. Human Serum Albumin
11.2.2. Recombinant Albumin
11.3. Market Value and Volume Forecast, by Application, 2019–2026
11.3.1. Human Serum Albumin Applications
11.3.1.1. Drug Formulation
11.3.1.2. Drug Delivery
11.3.1.3. Vaccines
11.3.1.4. Medical Device Coating
11.3.1.5. Culture Media & Stabilizers
11.3.1.6. Diagnostics
11.3.1.7. In Vitro Fertilization
11.3.2. Recombinant Albumin Applications
11.3.2.1. Drug Formulation
11.3.2.2. Drug Delivery
11.3.2.3. Vaccines
11.3.2.4. Medical Device Coating
11.3.2.5. Culture Media & Stabilizers
11.3.2.6. Diagnostics
11.3.2.7. In Vitro Fertilization
11.4. Market Value Forecast, by End-user, 2019–2026
11.4.1. Pharmaceutical & Biotechnology Industry
11.4.2. Research Institutes
11.4.3. Others
11.5. Market Value and Volume Forecast, by Country, 2019–2026
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. by Product Type
11.6.2. by Application
11.6.3. by End-user
11.6.4. by Country
12. Asia Pacific Albumin (as Excipient) Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value and Volume Forecast, by Product Type, 2019–2026
12.2.1. Human Serum Albumin
12.2.2. Recombinant Albumin
12.3. Market Value and Volume Forecast, by Application, 2019–2026
12.3.1. Human Serum Albumin Applications
12.3.1.1. Drug Formulation
12.3.1.2. Drug Delivery
12.3.1.3. Vaccines
12.3.1.4. Medical Device Coating
12.3.1.5. Culture Media & Stabilizers
12.3.1.6. Diagnostics
12.3.1.7. In Vitro Fertilization
12.3.2. Recombinant Albumin Applications
12.3.2.1. Drug Formulation
12.3.2.2. Drug Delivery
12.3.2.3. Vaccines
12.3.2.4. Medical Device Coating
12.3.2.5. Culture Media & Stabilizers
12.3.2.6. Diagnostics
12.3.2.7. In Vitro Fertilization
12.4. Market Value Forecast, by End-user, 2019–2026
12.4.1. Pharmaceutical & Biotechnology Industry
12.4.2. Research Institutes
12.4.3. Others
12.5. Market Value and Volume Forecast, by Country, 2019–2026
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. by Product Type
12.6.2. by Application
12.6.3. by End-user
12.6.4. by Country
13. Rest of the World Albumin (as Excipient) Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value and Volume Forecast, by Product Type, 2019–2026
13.2.1. Human Serum Albumin
13.2.2. Recombinant Albumin
13.3. Market Value and Volume Forecast by Application, 2019–2026
13.3.1. Human Serum Albumin Applications
13.3.1.1. Drug Formulation
13.3.1.2. Drug Delivery
13.3.1.3. Vaccines
13.3.1.4. Medical Device Coating
13.3.1.5. Culture Media & Stabilizers
13.3.1.6. Diagnostics
13.3.1.7. In Vitro Fertilization
13.3.2. Recombinant Albumin Applications
13.3.2.1. Drug Formulation
13.3.2.2. Drug Delivery
13.3.2.3. Vaccines
13.3.2.4. Medical Device Coating
13.3.2.5. Culture Media & Stabilizers
13.3.2.6. Diagnostics
13.3.2.7. In Vitro Fertilization
13.4. Market Value Forecast, by End-user, 2019–2026
13.4.1. Pharmaceutical & Biotechnology Industry
13.4.2. Research Institutes
13.4.3. Others
13.6. Market Attractiveness Analysis
13.6.1. by Product Type
13.6.2. by Application
13.6.3. by End-user
14. Competition Landscape
14.1. Market Player – Competition Matrix (by Tier and Size of Companies)
14.2. Market Share Analysis, by Company (2017)
14.3. Company Profiles
14.3.1. Albumedix A/S (Novozyme A/S)
14.3.1.1. Overview (HQ, Employee Strength, Business Segments)
14.3.1.2. Financials
14.3.1.3. Recent Developments
14.3.1.4. Strategy
14.3.2. Albumin Therapeutics, LLC
14.3.2.1. Overview (HQ, Employee Strength, Business Segments)
14.3.2.2. Financials
14.3.2.3. Recent Developments
14.3.2.4. Strategy
14.3.3. Biotest AG
14.3.3.1. Overview (HQ, Employee Strength, Business Segments)
14.3.3.2. Financials
14.3.3.3. Recent Developments
14.3.3.4. Strategy
14.3.4. CSL Behring LLC
14.3.4.1. Overview (HQ, Employee Strength, Business Segments)
14.3.4.2. Financials
14.3.4.3. Recent Developments
14.3.4.4. Strategy
14.3.5. Grifols International, S.A
14.3.5.1. Overview (HQ, Employee Strength, Business Segments)
14.3.5.2. Financials
14.3.5.3. Recent Developments
14.3.5.4. Strategy
14.3.6. HiMedia Laboratories Pvt. Ltd.
14.3.6.1. Overview (HQ, Employee Strength, Business Segments)
14.3.6.2. Financials
14.3.6.3. Recent Developments
14.3.6.4. Strategy
14.3.7. InVitria
14.3.7.1. Overview (HQ, Employee Strength, Business Segments)
14.3.7.2. Financials
14.3.7.3. Recent Developments
14.3.7.4. Strategy
14.3.8. Medxbio Pte Ltd.
14.3.8.1. Overview (HQ, Employee Strength, Business Segments)
14.3.8.2. Financials
14.3.8.3. Recent Developments
14.3.8.4. Strategy
14.3.9. Octapharma AG
14.3.9.1. Overview (HQ, Employee Strength, Business Segments)
14.3.9.2. Financials
14.3.9.3. Recent Developments
14.3.9.4. Strategy
14.3.10. RayBiotech, Inc.
14.3.10.1. Overview (HQ, Employee Strength, Business Segments)
14.3.10.2. Financials
14.3.10.3. Recent Developments
14.3.10.4. Strategy
14.3.11. SeraCare Life Sciences
14.3.11.1. Overview (HQ, Employee Strength, Business Segments)
14.3.11.2. Financials
14.3.11.3. Recent Developments
14.3.11.4. Strategy
14.3.12. Sigma-Aldrich Co. (Merck KGaA)
14.3.12.1. Overview (HQ, Employee Strength, Business Segments)
14.3.12.2. Financials
14.3.12.3. Recent Developments
14.3.12.4. Strategy
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers